Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 91

1.

Medical treatment of stable angina: A tailored therapeutic approach.

Manolis AJ, Poulimenos LE, Ambrosio G, Kallistratos MS, Lopez-Sendon J, Dechend R, Mancia G, Camm AJ.

Int J Cardiol. 2016 Oct 1;220:445-53. doi: 10.1016/j.ijcard.2016.06.150. Epub 2016 Jun 25. Review. No abstract available.

PMID:
27390968
2.

Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease.

Wallentin L, Held C, Armstrong PW, Cannon CP, Davies RY, Granger CB, Hagström E, Harrington RA, Hochman JS, Koenig W, Krug-Gourley S, Mohler ER 3rd, Siegbahn A, Tarka E, Steg PG, Stewart RA, Weiss R, Östlund O, White HD; STABILITY Investigators.

J Am Heart Assoc. 2016 Jun 21;5(6). pii: e003407. doi: 10.1161/JAHA.116.003407.

3.

Panethnic Differences in Blood Pressure in Europe: A Systematic Review and Meta-Analysis.

Modesti PA, Reboldi G, Cappuccio FP, Agyemang C, Remuzzi G, Rapi S, Perruolo E, Parati G; ESH Working Group on CV Risk in Low Resource Settings.

PLoS One. 2016 Jan 25;11(1):e0147601. doi: 10.1371/journal.pone.0147601. eCollection 2016. Review.

4.

Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke.

Zanchetti A, Liu L, Mancia G, Parati G, Grassi G, Stramba-Badiale M, Silani V, Bilo G, Corrao G, Zambon A, Scotti L, Zhang X, Guan TR, Zhang Y, Zhang X, Berge E, Redon J, Narkiewicz K, Dominiczak A, Nilsson P, Viigimaa M, Laurent S, Agabiti-Rosei E, Wu Z, Zhu D, Rodicio JL, Ruilope LM, Martell-Claros N, Pinto F, Schmieder RE, Burnier M, Banach M, Cifkova R, Farsang C, Konradi A, Lazareva I, Sirenko Y, Dorobantu M, Postadzhiyan A, Accetto R, Jelakovic B, Lovic D, Manolis AJ, Stylianou P, Dicker D, Wei G, Xu C, Xie H, Coca A, O'Brien J, Ford G; ESH-CHL-SHOT trial investigators.

J Hypertens. 2016 Mar;34(3):393-6. doi: 10.1097/HJH.0000000000000853. No abstract available.

PMID:
26780185
5.

Essential hypertension in the pathogenesis of age-related macular degeneration: a review of the current evidence.

Katsi VK, Marketou ME, Vrachatis DA, Manolis AJ, Nihoyannopoulos P, Tousoulis D, Vardas PE, Kallikazaros I.

J Hypertens. 2015 Dec;33(12):2382-8. doi: 10.1097/HJH.0000000000000766.

PMID:
26536087
6.

Detrimental role of hyperuricemia on the cardio-reno-vascular system.

Stack A, Manolis AJ, Ritz E.

Curr Med Res Opin. 2015;31 Suppl 2:21-6. doi: 10.1185/03007995.2015.1087984. Review.

PMID:
26414733
7.

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).

Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott PM, Fitzsimons D, Hatala R, Hindricks G, Kirchhof P, Kjeldsen K, Kuck KH, Hernandez-Madrid A, Nikolaou N, Norekvål TM, Spaulding C, Van Veldhuisen DJ; Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC).

Europace. 2015 Nov;17(11):1601-87. doi: 10.1093/europace/euv319. Epub 2015 Aug 29. No abstract available.

PMID:
26318695
8.

Adenosine as an Adjunct Therapy in ST Elevation Myocardial Infarction Patients: Myth or Truth?

Kassimis G, Davlouros P, Patel N, De Maria G, Kallistratos MS, Kharbanda RK, Manolis AJ, Alexopoulos D, Banning AP.

Cardiovasc Drugs Ther. 2015 Oct;29(5):481-93. doi: 10.1007/s10557-015-6606-5.

PMID:
26150100
9.

Serum uric acid and the risk of cardiovascular and renal disease.

Borghi C, Rosei EA, Bardin T, Dawson J, Dominiczak A, Kielstein JT, Manolis AJ, Perez-Ruiz F, Mancia G.

J Hypertens. 2015 Sep;33(9):1729-41; discussion 1741. doi: 10.1097/HJH.0000000000000701. Review.

PMID:
26136207
10.

5A.02: FITNESS STATUS AND RISK FOR ATRIAL FIBRILLATION.

Pittaras A, Faselis C, Doumas M, Manolis AJ, Grassos H, Kifnidis K, Kouremenos N, Papavasileiou M, Kallistratos M, Athanasiadis I, Kokkinos P.

J Hypertens. 2015 Jun;33 Suppl 1:e64. doi: 10.1097/01.hjh.0000467518.59380.e0.

PMID:
26102884
11.

The Mystery of High-density Lipoprotein: Quantity or Quality? Update on Therapeutic Strategies.

Katsi V, Kallistratos MS, Pavlidis AN, Karpettas N, Skoumas I, Pavleros N, Manolis AJ, Pitsavos C, Tousoulis D, Stefanadis C, Kallikazaros I.

Rev Cardiovasc Med. 2015;16(1):9-19.

PMID:
25813792
12.

Recent advances in the management of resistant hypertension.

Manolis AJ, Kallistratos MS, Doumas M, Pagoni S, Poulimenos L.

F1000Prime Rep. 2015 Jan 5;7:03. doi: 10.12703/P7-03. eCollection 2015. Review.

13.

[2014 ESC Guidelines on the diagnosis and treatment of aortic diseases].

Erbel R, Aboyans V, Boileau C, Bossone E, Di Bartolomeo R, Eggebrecht H, Evangelista A, Falk V, Frank H, Gaemperli O, Grabenwöger M, Haverich A, Iung B, Manolis AJ, Meijboom F, Nienaber CA, Roffi M, Rousseau H, Sechtem U, Sirnes PA, von Allmen RS, Vrints CJ; Grupa Robocza Europejskiego Towarzystwa Kardiologicznego (ESC) do spraw rozpoznawania i leczenia chorób aorty.

Kardiol Pol. 2014;72(12):1169-252. doi: 10.5603/KP.2014.0225. Polish. No abstract available.

PMID:
25524604
14.

Vasodilator β-blockers: a different class of antihypertensive agents?

Kallistratos MS, Poulimenos LE, Manolis AJ.

Future Cardiol. 2014 Nov;10(6):669-71. doi: 10.2217/fca.14.51. No abstract available.

15.

The J-curve in arterial hypertension: fact or fallacy?

Tsika EP, Poulimenos LE, Boudoulas KD, Manolis AJ.

Cardiology. 2014;129(2):126-35. doi: 10.1159/000362381. Epub 2014 Sep 10.

16.

2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC).

Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo RD, Eggebrecht H, Evangelista A, Falk V, Frank H, Gaemperli O, Grabenwöger M, Haverich A, Iung B, Manolis AJ, Meijboom F, Nienaber CA, Roffi M, Rousseau H, Sechtem U, Sirnes PA, Allmen RS, Vrints CJ; ESC Committee for Practice Guidelines.

Eur Heart J. 2014 Nov 1;35(41):2873-926. doi: 10.1093/eurheartj/ehu281. Epub 2014 Aug 29. No abstract available. Erratum in: Eur Heart J. 2015 Nov 1;36(41):2779.

17.

Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial.

Zanchetti A, Liu L, Mancia G, Parati G, Grassi G, Stramba-Badiale M, Silani V, Bilo G, Corrao G, Zambon A, Scotti L, Zhang X, Wang H, Zhang Y, Zhang X, Guan TR, Berge E, Redon J, Narkiewicz K, Dominiczak A, Nilsson P, Viigimaa M, Laurent S, Agabiti-Rosei E, Wu Z, Zhu D, Rodicio JL, Ruilope LM, Martell-Claros N, Pinto F, Schmieder RE, Burnier M, Banach M, Cifkova R, Farsang C, Konradi A, Lazareva I, Sirenko Y, Dorobantu M, Postadzhiyan A, Accetto R, Jelakovic B, Lovic D, Manolis AJ, Stylianou P, Erdine S, Dicker D, Wei G, Xu C, Xie H, Coca A, O'Brien J, Ford G.

J Hypertens. 2014 Sep;32(9):1888-97. doi: 10.1097/HJH.0000000000000254.

PMID:
24979303
18.

Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence.

Zanchetti A, Liu L, Mancia G, Parati G, Grassi G, Stramba-Badiale M, Silani V, Bilo G, Corrao G, Zambon A, Scotti L, Zhang X, Wang H, Zhang Y, Zhang X, Guan TR, Berge E, Redon J, Narkiewicz K, Dominiczak A, Nilsson P, Viigimaa M, Laurent S, Agabiti-Rosei E, Wu Z, Zhu D, Rodicio JL, Ruilope LM, Martell-Claros N, Pinto F, Schmieder RE, Burnier M, Banach M, Cifkova R, Farsang C, Konradi A, Lazareva I, Sirenko Y, Dorobantu M, Postadzhiyan A, Accetto R, Jelakovic B, Lovic D, Manolis AJ, Stylianou P, Erdine S, Dicker D, Wei G, Xu C, Xie H, Coca A, O'Brien J, Ford G.

J Hypertens. 2014 Sep;32(9):1741-50. doi: 10.1097/HJH.0000000000000253. Review.

PMID:
24979302
19.

Efficacy and safety of ivabradine in patients with chronic systolic heart failure according to blood pressure level in SHIFT.

Komajda M, Böhm M, Borer JS, Ford I, Robertson M, Manolis AJ, Tavazzi L, Swedberg K; SHIFT Investigators.

Eur J Heart Fail. 2014 Jul;16(7):810-6. doi: 10.1002/ejhf.114. Epub 2014 Jun 24.

20.

The value of left ventricular global longitudinal strain assessed by three-dimensional strain imaging in the early detection of anthracyclinemediated cardiotoxicity.

Mornoş C, Manolis AJ, Cozma D, Kouremenos N, Zacharopoulou I, Ionac A.

Hellenic J Cardiol. 2014 May-Jun;55(3):235-44.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk